Magneclo

Magnesium chloride hexahydrate, the active ingredient in Magneclo, is an electrolyte presented as a solution for injection for intravenous use. It treats magnesium deficiency and related electrolyte disturbances in hospitalized patients.

GNH USA supplies Magneclo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Magneclo, an intravenous magnesium supplement, is used to correct electrolyte imbalances.

Magnesium deficiency: restores normal magnesium concentrations in patients with low serum levels. Hypomagnesemia: raises serum magnesium to therapeutic range during acute care. Electrolyte replacement: supports overall electrolyte homeostasis in surgical or critical‑care settings.

Magneclo may be associated with a range of adverse reactions.

Common Side Effects: - Injection site pain or erythema - Transient flushing or warmth - Mild hypotension - Nausea or headache

Serious or Rare Side Effects: - Hypermagnesemia leading to cardiac arrhythmia - Severe hypotension or cardiovascular collapse - Respiratory depression or muscle weakness - Anaphylactic or severe allergic reaction

Magneclo requires careful clinical monitoring before and during administration.

Renal impairment: monitor serum magnesium and adjust infusion rate. Cardiac disease: use cautiously in patients with conduction abnormalities. Concurrent calcium therapy: assess for additive effects on cardiac conduction. Pregnancy: safety not established; weigh potential benefits against risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magneclo can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Neuromuscular blocking agents: may potentiate blockade. - Calcium channel blockers: risk of additive hypotension. - Digoxin: increased risk of toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Loop diuretics: may exacerbate magnesium loss. - Antacids containing aluminum or magnesium: assess cumulative magnesium load.